BIOMAT Database Logo BIOMAT Database Logo

Effect of hypolipidemic drugs, nafenopin and clofibrate, on the concentration of ligandin and Z protein in rat liver. 1975

G Fleischner, and D K Meijer, and W G Levine, and Z Gatmaitan, and R Gluck, and I M Arias

UI MeSH Term Description Entries
D007122 Immunoelectrophoresis A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009255 Nafenopin A peroxisome proliferator that is used experimentally to promote liver tumors. It has been used as an antihyperlipoproteinemic agent. CH-13437,Melipan,Nafenoic Acid,SU-13,437,Acid, Nafenoic,CH 13437,CH13437,SU 13,437,SU13,437
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D011422 Propionates Derivatives of propionic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxyethane structure. Propanoate,Propanoic Acid,Propionate,Propanoates,Propanoic Acid Derivatives,Propanoic Acids,Propionic Acid Derivatives,Propionic Acids,Acid, Propanoic,Acids, Propanoic,Acids, Propionic,Derivatives, Propanoic Acid,Derivatives, Propionic Acid
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D005779 Immunodiffusion Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction. Gel Diffusion Tests,Diffusion Test, Gel,Diffusion Tests, Gel,Gel Diffusion Test,Immunodiffusions,Test, Gel Diffusion,Tests, Gel Diffusion

Related Publications

G Fleischner, and D K Meijer, and W G Levine, and Z Gatmaitan, and R Gluck, and I M Arias
Studies on the hepatomegaly caused by the hypolipidemic drugs nafenopin and clofibrate.
September 1972, Toxicology and applied pharmacology,
G Fleischner, and D K Meijer, and W G Levine, and Z Gatmaitan, and R Gluck, and I M Arias
Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver.
April 1990, Carcinogenesis,
G Fleischner, and D K Meijer, and W G Levine, and Z Gatmaitan, and R Gluck, and I M Arias
The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes.
February 1978, The American journal of pathology,
G Fleischner, and D K Meijer, and W G Levine, and Z Gatmaitan, and R Gluck, and I M Arias
[Ligandin and Z-protein].
August 1985, Nihon rinsho. Japanese journal of clinical medicine,
G Fleischner, and D K Meijer, and W G Levine, and Z Gatmaitan, and R Gluck, and I M Arias
Lack of covalent binding to rat liver DNA of the hypolipidemic drugs clofibrate and fenofibrate.
February 1981, Toxicology letters,
G Fleischner, and D K Meijer, and W G Levine, and Z Gatmaitan, and R Gluck, and I M Arias
Study of nafenopin, a hypolipidemic drug on liver metabolism.
January 1989, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement,
G Fleischner, and D K Meijer, and W G Levine, and Z Gatmaitan, and R Gluck, and I M Arias
Mitogenic effect in mouse liver induced by a hypolipidemic drug, nafenopin.
April 1977, Virchows Archiv. B, Cell pathology,
G Fleischner, and D K Meijer, and W G Levine, and Z Gatmaitan, and R Gluck, and I M Arias
Ligandin and Z protein in binding of thyroid hormones by the liver.
April 1976, The American journal of physiology,
G Fleischner, and D K Meijer, and W G Levine, and Z Gatmaitan, and R Gluck, and I M Arias
Effect of nafenopin and clofibrate on uptake and utilization of labeled thymidine for DNA synthesis in rat liver and kidney.
January 1988, Carcinogenesis,
G Fleischner, and D K Meijer, and W G Levine, and Z Gatmaitan, and R Gluck, and I M Arias
Effects of the hepatocarcinogenic peroxisome-proliferating hypolipidemic agents clofibrate and nafenopin on the rat liver cell membrane enzymes gamma-glutamyltranspeptidase and alkaline phosphatase and on the early stages of liver carcinogenesis.
December 1984, Carcinogenesis,
Copied contents to your clipboard!